Home >> Tag Archives: Sedia Biosciences—

Tag Archives: Sedia Biosciences—

NIH gives $1.8 million for POC HIV test

Sept. 16, 2016—Sedia Biosciences will receive an award of a $1.8 million phase two National Institutes of Health Small Business Innovation Research grant to accelerate development of Sedia’s Asanté HIV-1 Rapid Recency™ Assay. The new test, using a portable handheld reader, can estimate how recently an HIV infection occurred from from a fingerstick drop of blood, generating results within 20 ...

Read More »